Skip to content

Pfizer CEO: ‘Most Likely Scenario’ is Annual Revaccination Against Covid

Pfizer CEO Albert Bourla doesn’t project that Americans will ever be able to return to a normal life without his precious ‘vaccines.’

“There will be a return to normal life within a year, Pfizer CEO and Chairman Albert Bourla said on Sunday, adding that it’s likely annual Covid vaccination shots will be necessary,” CNBC reported.

“Within a year I think we will be able to come back to normal life,” Bourla said on ABC’s “This Week.”

“I don’t think that this means that the variants will not continue coming, and I don’t think that this means that we should be able to live our lives without having vaccinations,” Bourla added. “But that, again, remains to be seen.”

Moderna CEO Stéphane Bancel made statements that echoed Borla’s about the timeline of life returning to ‘normal.’

“As of today, in a year, I assume,” Bancel told Swiss newspaper Neue Zuercher Zeitung.

Pfizer’s Bourla then added that an annual coronavirus ‘vaccine’ shot will be needed.

“The most likely scenario for me is that, because the virus is spread all over the world, that it will continue seeing new variants that are coming out,” Bourla said. “Also we will have vaccines that they will last at least a year, and I think the most likely scenario is annual vaccination, but we don’t know really, we need to wait and see the data.”

That’s quite the business model: Pharmaceutical companies are asked about when people will be allowed to return to normal. The answer? When people take my vaccines, even due to government coercion, for the rest of their lives.


Biden’s Vaccine Mandate Suffers Another Devastating Blow: ‘This Unlawful Mandate is Now Blocked in All 50 States’

"*" indicates required fields

Who would you vote for? Trump or DeSantis?*
This poll gives you free access to our premium politics newsletter. Unsubscribe at any time.
This field is for validation purposes and should be left unchanged.

OPINION: This article contains commentary which reflects the author's opinion.